{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:34:17Z","timestamp":1776839657236,"version":"3.51.2"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The muscle is an endocrine organ controlling metabolic homeostasis. Irisin and myostatin are key myokines mediating this process. Acromegaly is a chronic disease with a wide spectrum of complications, including metabolic disturbances.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose<\/jats:title><jats:p>To examine the influence of acromegaly on irisin and myostatin secretion and their contribution to metabolic profile and body composition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>In 43 patients with acromegaly and 60 controls, serum levels of irisin, myostatin, growth hormone (GH), insulin-like growth factor 1 (IGF-1), parameters of glucose, and lipid metabolism were determined. Body composition was assessed with dual-energy x-ray absorptiometry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The irisin concentration was significantly lower in patients with acromegaly compared to controls (3.91 <jats:italic>vs<\/jats:italic>. 5.09 \u03bcg\/ml, <jats:italic>p<\/jats:italic> = 0.006). There were no correlations between irisin and GH\/IGF-1 levels. In the study group, irisin was negatively correlated with fasting insulin (<jats:italic>r<\/jats:italic> = \u22120.367; <jats:italic>p<\/jats:italic> = 0.042), HOMA-IR (<jats:italic>r<\/jats:italic> = \u22120.510; <jats:italic>p<\/jats:italic> = 0.011), and atherogenic factors: Castelli I (<jats:italic>r<\/jats:italic> = \u22120.416; <jats:italic>p<\/jats:italic> = 0.005), Castelli II (<jats:italic>r<\/jats:italic> = \u22120.400; <jats:italic>p<\/jats:italic> = 0.001), and atherogenic coefficient (AC) (<jats:italic>r<\/jats:italic> = \u22120.417; <jats:italic>p<\/jats:italic> = 0.05). Irisin and myostatin concentrations were also lower in acromegalics with insulin resistance than without (2.80 <jats:italic>vs<\/jats:italic>. 4.18 \u03bcg\/ml, <jats:italic>p<\/jats:italic> = 0.047; 81.46 <jats:italic>vs<\/jats:italic>. 429.58 ng\/L, <jats:italic>p<\/jats:italic> = 0.018, respectively). There were no differences between study group and controls in myostatin concentration. Myostatin levels negatively correlated with GH (<jats:italic>r<\/jats:italic> = \u22120.306; <jats:italic>p<\/jats:italic> = 0.049), HOMA-IR (<jats:italic>r<\/jats:italic> = \u22120.046; <jats:italic>p<\/jats:italic> = 0.411), and insulin levels (<jats:italic>r<\/jats:italic> = \u22120.429; <jats:italic>p<\/jats:italic> = 0.016).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Decreased irisin concentrations in acromegaly may suggest impaired hormonal muscle function contributing to metabolic complications in this disorder. However, learning more about the association between myostatin and GH in acromegaly requires further studies. Nevertheless, it appears that myostatin is not critical for muscle mass regulation in acromegaly.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.728734","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T06:14:57Z","timestamp":1635833697000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Myokines in Acromegaly: An Altered Irisin Profile"],"prefix":"10.3389","volume":"12","author":[{"given":"\u0141ukasz","family":"Mizera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jowita","family":"Halupczok-\u017by\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kola\u010dkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Zembska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u0119drzej","family":"Grzegrz\u00f3\u0142ka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"J\u0119drzejuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Bolanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Daroszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.49","article-title":"Muscles, Exercise and Obesity: Skeletal Muscle as a Secretory Organ","volume":"8","author":"Pedersen","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3140485","article-title":"Noradrenaline Increases Glucose Transport Into Brown Adipocytes in Culture by a Mechanism Different From That of Insulin","volume":"314","author":"Shimizu","year":"1996","journal-title":"Biochem J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205058","article-title":"The Beige Adipocyte as a Therapy for Metabolic Diseases","volume":"20","author":"Lizcano","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2015.199","article-title":"Irisin Improves Fatty Acid Oxidation and Glucose Utilization in Type 2 Diabetes by Regulating the AMPK Signaling Pathway","volume":"40","author":"Xin","year":"2016","journal-title":"Int J Obes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/me.2014-1353","article-title":"Irisin, a Novel Myokine, Regulates Glucose Uptake in Skeletal Muscle Cells via AMPK","volume":"29","author":"Lee","year":"2015","journal-title":"Mol Endocrinol (Baltimore Md.)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/db17-0002","article-title":"The Myokine Irisin Is Released in Response to Saturated Fatty Acids and Promotes Pancreatic \u03b2-Cell Survival and Insulin Secretion","volume":"66","author":"Natalicchio","year":"2017","journal-title":"Diabetes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0175498","DOI":"10.1371\/journal.pone.0175498","article-title":"Effects and Underlying Mechanisms of Irisin on the Proliferation and Apoptosis of Pancreatic \u03b2 Cells","volume":"12","author":"Liu","year":"2017","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000495395","article-title":"Irisin Ameliorates Glucolipotoxicity-Associated \u03b2-Cell Dysfunction and Apoptosis via AMPK Signaling and Anti-Inflammatory Actions","volume":"51","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2019.170120","article-title":"Irisin Reverses Insulin Resistance in C2C12 Cells via the P38-MAPK-PGC-1\u03b1 Pathway","volume":"119","author":"Ye","year":"2019","journal-title":"Peptides"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.1006","article-title":"Metformin-Induced Autophagy and Irisin Improves INS-1 Cell Function and Survival in High-Glucose Environment via AMPK\/SIRT1\/PGC-1\u03b1 Signal Pathway","volume":"7","author":"Li","year":"2019","journal-title":"Food Sci Nutr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e4937","DOI":"10.1371\/journal.pone.0004937","article-title":"Myostatin Inhibition in Muscle, But Not Adipose Tissue, Decreases Fat Mass and Improves Insulin Sensitivity","volume":"4","author":"Guo","year":"2009","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.23.12457","article-title":"Double Muscling in Cattle Due to Mutations in the Myostatin Gene","volume":"94","author":"McPherron","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin Mutation Associated With Gross Muscle Hypertrophy in a Child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e3181e0b9a8","article-title":"Myostatin Decreases With Aerobic Exercise and Associates With Insulin Resistance","volume":"42","author":"Hittel","year":"2010","journal-title":"Med Sci Sports Exercise"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2079-7","article-title":"Myostatin-Deficient Mice Exhibit Reduced Insulin Resistance Through Activating the AMP-Activated Protein Kinase Signalling Pathway","volume":"54","author":"Zhang","year":"2011","journal-title":"Diabetologia"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2015.200","article-title":"Inhibition of Myostatin in Mice Improves Insulin Sensitivity via Irisin-Mediated Cross Talk Between Muscle and Adipose Tissues","volume":"40","author":"Dong","year":"2016","journal-title":"Int J Obes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.09.044","article-title":"Transgenic Expression of Myostatin Propeptide Prevents Diet-Induced Obesity and Insulin Resistance","volume":"337","author":"Zhao","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2018.365","article-title":"Cardiovascular Complications of Acromegaly","volume":"14","author":"Mizera","year":"2018","journal-title":"Acta Endocrinologica (Bucharest Romania: 2005)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz096","article-title":"A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update","volume":"105","author":"Giustina","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.04.014","article-title":"Current and Emerging Aspects of Diabetes Mellitus in Acromegaly","volume":"27","author":"Frara","year":"2016","journal-title":"Trends Endocrinol Metabolism: TEM"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020563","article-title":"Dose Dependency of the Pharmacokinetics and Acute Lipolytic Actions of Growth Hormone","volume":"87","author":"Hansen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(92)90147-3","article-title":"Dose-Response Studies on the Metabolic Effects of a Growth Hormone Pulse in Humans","volume":"41","author":"M\u00f8ller","year":"1992","journal-title":"Metabolism: Clin Exp"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2780","article-title":"Lower Visceral and Subcutaneous But Higher Intermuscular Adipose Tissue Depots in Patients With Growth Hormone and Insulin-Like Growth Factor I Excess Due to Acromegaly","volume":"93","author":"Freda","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.02.005","article-title":"The Impact of Adipose Tissue on Insulin Resistance in Acromegaly","volume":"27","author":"Olarescu","year":"2016","journal-title":"Trends Endocrinol Metabolism: TEM"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/dmrr.919","article-title":"The Role of Insulin-Like Growth Factor-I and Its Binding Proteins in Glucose Homeostasis and Type 2 Diabetes","volume":"25","author":"Rajpathak","year":"2009","journal-title":"Diabetes\/Metabolism Res Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.12.024","article-title":"Insulin-Like Growth Factor I Reduces Lipid Oxidation and Foam Cell Formation via Downregulation of 12\/15-Lipoxygenase","volume":"238","author":"Sukhanov","year":"2015","journal-title":"Atherosclerosis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.beem.2019.02.001","article-title":"National Acromegaly Registries","volume":"33","author":"Maione","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1530\/EC-14-0021","article-title":"Prevalence of Diabetes Mellitus in Patients With Acromegaly","volume":"3","author":"Dreval","year":"2014","journal-title":"Endocrine Connections"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00496","article-title":"Editorial: Health-Related Complications of Acromegaly","volume":"11","author":"Bolanowski","year":"2020","journal-title":"Front Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocrine Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/js.2017-00334","article-title":"Increased Risk of Persistent Glucose Disorders After Control of Acromegaly","volume":"1","author":"Rochette","year":"2017","journal-title":"J\u00a0Endocrine Soc"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: An Endocrine Society Clinical Practice Guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","article-title":"Insulin Resistance Indices in Population-Based Study and Their Predictive Value in Defining Metabolic Syndrome","volume":"59","author":"Szurkowska","year":"2005","journal-title":"Przeglad Epidemiologiczny"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2014.07.029","article-title":"Prevalence of Atherogenic Dyslipidemia in Spanish Hypertensive Patients and Its Relationship With Blood Pressure Control and Silent Organ Damage","volume":"68","author":"de la Sierra","year":"2015","journal-title":"Rev Espa\u00f1ola Cardiolog\u00eda (English Edition)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"B37","article-title":"Atherogenic Index of Plasma, Castelli Risk Index and Atherogenic Coefficient- New Parameters in Assessing Cardiovascular Risk","volume":"3","author":"Bhardwaj","year":"2013","journal-title":"Int J Pharm Bio Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1590\/S1807-59322008000400003","article-title":"High Ratio of Triglycerides to HDL-Cholesterol Predicts Extensive Coronary Disease","volume":"63","author":"da Luz","year":"2008","journal-title":"Clinics (Sao Paulo Brazil)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S38594","article-title":"Acromegaly: The Disease, Its Impact on Patients, and Managing the Burden of Long-Term Treatment","volume":"6","author":"Adelman","year":"2013","journal-title":"Int J Gen Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0058-5","article-title":"A Consensus Statement on Acromegaly Therapeutic Outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2373","article-title":"Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome","volume":"98","author":"Park","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0124100","DOI":"10.1371\/journal.pone.0124100","article-title":"Circulating Irisin Levels Are Positively Associated With Metabolic Risk Factors in Sedentary Subjects","volume":"10","author":"Moreno","year":"2015","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1511","article-title":"Circulating Serum Irisin Levels in Obesity and Type 2 Diabetes Mellitus","volume":"68","author":"Shoukry","year":"2016","journal-title":"IUBMB Life"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/osp4.43","article-title":"Relationships Between Serum Irisin Levels and Metabolic Parameters in Japanese Patients With Obesity","volume":"2","author":"Fukushima","year":"2016","journal-title":"Obes Sci Pract"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.02.006","article-title":"Association Between Circulating Irisin and Insulin Resistance in Non-Diabetic Adults: A Meta-Analysis","volume":"65","author":"Qiu","year":"2016","journal-title":"Metabolism"},{"key":"B46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12902-019-0479-8","article-title":"The Association of Circulating Irisin With Metabolic Risk Factors in Chinese Adults: A Cross-Sectional Community-Based Study","volume":"19","author":"Tang","year":"2019","journal-title":"BMC Endocrine Disord"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0154319","DOI":"10.1371\/journal.pone.0154319","article-title":"Circulating Irisin Concentrations Are Associated With a Favourable Lipid Profile in the General Population","volume":"11","author":"Oelmann","year":"2016","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e72858","DOI":"10.1371\/journal.pone.0072858","article-title":"Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo","volume":"8","author":"Gouni-Berthold","year":"2013","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00320","article-title":"Circulating Irisin Is Reduced in Male Patients With Type 1 and Type 2 Myotonic Dystrophies","volume":"8","author":"Dozio","year":"2017","journal-title":"Front Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.13030","article-title":"Circulating Irisin Levels as a Predictive Biomarker for Sarcopenia: A Cross-Sectional Community-Based Study","volume":"17","author":"Chang","year":"2017","journal-title":"Geriatrics Gerontology Int"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S249090","article-title":"Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing\u2019s Disease","volume":"13","author":"Guarnotta","year":"2020","journal-title":"Diabetes Metab Syndrome Obesity: Targets Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2014.07.021","article-title":"Serum Irisin Levels and Thyroid Function\u2013Newly Discovered Association","volume":"60","author":"Ruchala","year":"2014","journal-title":"Peptides"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3233\/IES-160635","article-title":"Parameters of Knee Isokinetic Dynamometry in Individuals With Acromegaly: Association With Growth Hormone Levels and General Fatigue","volume":"24","author":"Walchan","year":"2016","journal-title":"Isokinetics Exercise Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1123\/japa.2016-0100","article-title":"Balance Control and Peripheral Muscle Function in Aging: A Comparison Between Individuals With Acromegaly and Healthy Subjects","volume":"25","author":"Homem","year":"2017","journal-title":"J Aging Phys Activity"},{"key":"B55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4158\/EP.11.1.18","article-title":"Acromegaly as An Endocrine Form of Myopathy: Case Report and Review of Literature","volume":"11","author":"McNab","year":"2005","journal-title":"Endocrine Pract"},{"key":"B56","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4103\/0301-4738.86330","article-title":"Restrictive Extraocular Myopathy: A Presenting Feature of Acromegaly","volume":"59","author":"Heireman","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(70)92072-6","article-title":"Myopathy in Acromegaly","volume":"2","author":"Mastaglia","year":"1970","journal-title":"Lancet (London England)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(83)80042-9","article-title":"Myopathy in Acromegaly. A Case Study","volume":"177","author":"Brumback","year":"1983","journal-title":"Pathol Res Pract"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6041.914","article-title":"Muscle Changes in Acromegaly","volume":"2","author":"Nagulesparen","year":"1976","journal-title":"Br Med J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.25.7.638","article-title":"Neuromuscular Complications of Acromegaly","volume":"25","author":"Pickett","year":"1975","journal-title":"Neurology"},{"key":"B61","article-title":"The Imbalance of Cathepsin B-Like Activity in Acromegalic Patients\u2013Preliminary Report","volume":"31","author":"Daroszewski","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-019-00151-3","article-title":"Increased Circulating Levels of Irisin Are Associated With Cardiovascular Risk Factors in Subjects With Acromegaly","volume":"18","author":"Calan","year":"2019","journal-title":"Hormones (Athens Greece)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2468","article-title":"A Structural and Functional Acromegaly Classification","volume":"100","author":"Cuevas-Ramos","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01780.x","article-title":"Growth Hormone, Acromegaly, and Heart Failure: An Intricate Triangulation","volume":"59","author":"Sacc\u00e0","year":"2003","journal-title":"Clin Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24298","article-title":"IGF-1 Induces IP3 -Dependent Calcium Signal Involved in the Regulation of Myostatin Gene Expression Mediated by NFAT During Myoblast Differentiation","volume":"228","author":"Vald\u00e9s","year":"2013","journal-title":"J Cell Physiol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2001.281.6.E1159","article-title":"Comparison of GH, IGF-I, and Testosterone With mRNA of Receptors and Myostatin in Skeletal Muscle in Older Men","volume":"281","author":"Marcell","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2008.161521","article-title":"The Decrease in Mature Myostatin Protein in Male Skeletal Muscle Is Developmentally Regulated by Growth Hormone","volume":"587","author":"Oldham","year":"2009","journal-title":"J Physiol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030497","article-title":"Myostatin Is a Skeletal Muscle Target of Growth Hormone Anabolic Action","volume":"88","author":"Liu","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2018.12.001","article-title":"GH Replacement Titrated to Serum IGF-1 Does Not Reduce Concentrations of Myostatin in Blood or Skeletal Muscle","volume":"44","author":"Paul","year":"2019","journal-title":"Growth Hormone IGF Res: Off J Growth Hormone Res Soc Int IGF Res Soc"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13147","article-title":"Growth Hormone (GH) Enhances Anaerobic Capacity: Impact on Physical Function and Quality of Life in Adults With GH Deficiency","volume":"85","author":"Chikani","year":"2016","journal-title":"Clin Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.153","article-title":"Regulation of Muscle Mass by Growth Hormone and IGF-I","volume":"154","author":"Velloso","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0906","article-title":"Intact Insulin and Insulin-Like Growth Factor-I Receptor Signaling Is Required for Growth Hormone Effects on Skeletal Muscle Growth and Function In Vivo","volume":"146","author":"Kim","year":"2005","journal-title":"Endocrinology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1530\/JME-13-0208","article-title":"Action of GH on Skeletal Muscle Function: Molecular and Metabolic Mechanisms","volume":"52","author":"Chikani","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20216","article-title":"Aerobic Exercise+Weight Loss Decreases Skeletal Muscle Myostatin Expression and Improves Insulin Sensitivity in Older Adults","volume":"21","author":"Ryan","year":"2013","journal-title":"Obes (Silver Spring Md.)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032047","article-title":"Changes in Muscle Myostatin Expression in Obese Subjects After Weight Loss","volume":"89","author":"Milan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B76","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/apha.12631","article-title":"Myostatin in Relation to Physical Activity and Dysglycaemia and Its Effect on Energy Metabolism in Human Skeletal Muscle Cells","volume":"217","author":"Hjorth","year":"2016","journal-title":"Acta Physiologica (Oxford England)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e6575","DOI":"10.1371\/journal.pone.0006575","article-title":"Gene Expression in Skeletal Muscle Biopsies From People With Type 2 Diabetes and Relatives: Differential Regulation of Insulin Signaling Pathways","volume":"4","author":"Palsgaard","year":"2009","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e37236","DOI":"10.1371\/journal.pone.0037236","article-title":"Plasma and Muscle Myostatin in Relation to Type 2 Diabetes","volume":"7","author":"Brandt","year":"2012","journal-title":"PloS One"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2018.11.010","article-title":"Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis","volume":"29","author":"Delanaye","year":"2019","journal-title":"J Renal Nutrition: Off J Council Renal Nutr Natl Kidney Foundation"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/srep08889","article-title":"Irisin \u2013 a Myth Rather Than an Exercise-Inducible Myokine","volume":"5","author":"Albrecht","year":"2015","journal-title":"Sci Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.08.001","article-title":"Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry","volume":"22","author":"Jedrychowski","year":"2015","journal-title":"Cell Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.06.005","article-title":"An Update on the Validity of Irisin Assays and the Link Between Irisin and Hepatic Metabolism","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism: Clin Exp"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.728734\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T06:15:01Z","timestamp":1635833701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.728734\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":82,"alternative-id":["10.3389\/fendo.2021.728734"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.728734","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"article-number":"728734"}}